{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T01:18:39Z","timestamp":1793841519036,"version":"4.6.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T00:00:00Z","timestamp":1703116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T00:00:00Z","timestamp":1703116800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Oral Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that can cause a range of symptoms, including oral mucosal lesions (OMLs). The prevalence of OMLs in SLE patients and their associated factors have been studied in various regions, but the results are inconsistent. This study aims to evaluate the prevalence of OMLs in patients with SLE.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Observational studies of OML prevalence in SLE patients published before 2022 were retrieved from PubMed, Embase, Web of Science, Google Scholar, and the Cochrane Library without language restriction. The quality of the studies was assessed using the Newcastle-Ottawa Scale (NOS) and Agency for Healthcare Research and Quality (AHRQ).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Our meta-analysis included 113 studies with a total of 53,307 SLE patients. We found that the prevalence of OMLs in SLE patients was 31% (95% CI: 28%, 35%), with oral ulcers being present in 30% of SLE patients (95% CI: 26%, 33%). Subgroup analysis showed that the prevalence of OMLs varied significantly by region, disease activity, and sample size (<jats:italic>p<\/jats:italic>\u2009\u2264\u20090.01). However, gender and year of publication had little effect on the prevalence of OMLs (<jats:italic>p<\/jats:italic>\u2009=\u20090.78 and 0.30, respectively). Oral ulcers were significantly associated with age of onset (<jats:italic>p<\/jats:italic>\u2009=\u20090.02), geographic location (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01), and race (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01). We also found that the prevalence of oral erythema was 9%, oral candidiasis was 9%, petechiae was 8%, cheilitis was 6%, and white plaque was 3%.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our analysis showed that the prevalence of OMLs varied significantly by region and disease activity, and child-onset patients of Indian, Malay, and Caucasian descent were more likely to have oral ulcers. The high prevalence of OML in SLE patients emphasizes the importance of regular oral examination and management in the comprehensive care of individuals with SLE.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12903-023-03783-5","type":"journal-article","created":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T12:02:40Z","timestamp":1703160160000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Prevalence of oral mucosal lesions in patients with systemic Lupus Erythematosus: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"23","author":[{"given":"Fei","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanying","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinna","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwei","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,21]]},"reference":[{"key":"3783_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2018.11.001","volume":"96","author":"A Fava","year":"2019","unstructured":"Fava A, Petri M. Systemic Lupus Erythematosus: diagnosis and clinical management. J Autoimmun. 2019;96:1\u201313.","journal-title":"J Autoimmun"},{"key":"3783_CR2","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1177\/0961203306072311","volume":"15","author":"C Lau","year":"2006","unstructured":"Lau C, Yin G, Mok M. Ethnic and geographical differences in systemic Lupus Erythematosus: an overview. Lupus. 2006;15:715\u20139.","journal-title":"Lupus"},{"key":"3783_CR3","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/j.1445-5994.1995.tb02843.x","volume":"25","author":"D Grennan","year":"1995","unstructured":"Grennan D, Bossingham D. Systemic Lupus Erythematosus (SLE): different prevalences in different populations of Australian aboriginals. Aust N Z J Med. 1995;25:182\u20133.","journal-title":"Aust N Z J Med"},{"key":"3783_CR4","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.autrev.2007.11.014","volume":"7","author":"J Rovensk\u00fd","year":"2008","unstructured":"Rovensk\u00fd J, Tuchy\u0148ov\u00e1 A. Systemic Lupus Erythematosus in the elderly. Autoimmun Rev. 2008;7:235\u20139.","journal-title":"Autoimmun Rev"},{"key":"3783_CR5","unstructured":"Nalbanti P, Stefanidou S, Alfantaki S, Siamopoulou A, Trachana M, Pratsidou-Gertsi P. A 5-year multicenter comparative study between patients with juvenile and adult-onset systemic Lupus Erythematosus. Pediatriki. 2012:72\u201385."},{"key":"3783_CR6","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1097\/01.md.0000147737.57861.7c","volume":"83","author":"J Boddaert","year":"2004","unstructured":"Boddaert J, Amoura Z, Wechsler B, Godeau P, Piette J-C. Late-onset systemic Lupus Erythematosus: a personal series of 47 patients and pooled analysis of 714 cases in the literature. Med (Baltim). 2004;83:348\u201359.","journal-title":"Med (Baltim)"},{"key":"3783_CR7","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1177\/0961203308089695","volume":"17","author":"S Appenzeller","year":"2008","unstructured":"Appenzeller S, Pereira D, Costallat L. Greater accrual damage in late-onset systemic Lupus Erythematosus: a long-term follow-up study. Lupus. 2008;17:1023\u20138.","journal-title":"Lupus"},{"key":"3783_CR8","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1136\/ard.50.10.702","volume":"50","author":"J Font","year":"1991","unstructured":"Font J, Pallares L, Cervera R, Lopez-Soto A, Navarro M, Bosch X, et al. Systemic Lupus Erythematosus in the elderly: clinical and immunological characteristics. Ann Rheum Dis. 1991;50:702\u20135.","journal-title":"Ann Rheum Dis"},{"key":"3783_CR9","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1002\/art.41632","volume":"73","author":"PM Izmirly","year":"2021","unstructured":"Izmirly PM, Parton H, Wang L, McCune WJ, Lim SS, Drenkard C, et al. Prevalence of systemic Lupus Erythematosus in the United States: estimates from a meta-analysis of the Centers for Disease Control and Prevention National Lupus Registries. Arthritis Rheumatol. 2021;73:991\u20136.","journal-title":"Arthritis Rheumatol"},{"key":"3783_CR10","first-page":"87","volume":"23","author":"AS Al-Arfaj","year":"2002","unstructured":"Al-Arfaj AS, Al-Balla SR, Al-Dalaan AN, Al-Saleh SS, Bahabri SA, Mousa MM, et al. Prevalence of systemic Lupus Erythematosus in central Saudi Arabia. Saudi Med J. 2002;23:87\u20139.","journal-title":"Saudi Med J"},{"key":"3783_CR11","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1136\/ard.45.8.645","volume":"45","author":"H Taylor","year":"1986","unstructured":"Taylor H, Stein C. Systemic Lupus Erythematosus in Zimbabwe. Ann Rheum Dis. 1986;45:645\u20138.","journal-title":"Ann Rheum Dis"},{"key":"3783_CR12","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1177\/0961203313512881","volume":"23","author":"E Nasonov","year":"2014","unstructured":"Nasonov E, Soloviev S, Davidson J, Lila A, Ivanova R, Togizbayev G, et al. The prevalence and incidence of systemic Lupus Erythematosus (SLE) in selected cities from three Commonwealth of Independent States countries (the Russian Federation, Ukraine and Kazakhstan). Lupus. 2014;23:213\u20139.","journal-title":"Lupus"},{"key":"3783_CR13","unstructured":"Cassidy JT, Petty RE, Laxer RM, Lindsley CB. Textbook of pediatric rheumatology E-Book. Elsevier Health Sciences; 2010."},{"key":"3783_CR14","first-page":"1381","volume":"82","author":"AC Chi","year":"2010","unstructured":"Chi AC, Neville BW, Krayer JW, Gonsalves WC. Oral manifestations of systemic Disease. Am Fam Physician. 2010;82:1381\u20138.","journal-title":"Am Fam Physician"},{"key":"3783_CR15","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0300-9785(84)80079-4","volume":"13","author":"M Schi\u00f8dt","year":"1984","unstructured":"Schi\u00f8dt M. Oral manifestations of Lupus Erythematosus. Int J Oral Surg. 1984;13:101\u201347.","journal-title":"Int J Oral Surg"},{"key":"3783_CR16","doi-asserted-by":"publisher","first-page":"105906","DOI":"10.1016\/j.ijsu.2021.105906","volume":"88","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg. 2021;88:105906.","journal-title":"Int J Surg"},{"key":"3783_CR17","unstructured":"WY FD. Q. Prevalence of oral mucosal lesions in patients with systemic Lupus Erythematosus: a systematic review and meta-analysis.PROSPERO 2022 CRD42022307095. 2022. https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?ID=CRD42022307095."},{"key":"3783_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol. 2014;14:1\u201313.","journal-title":"BMC Med Res Methodol"},{"key":"3783_CR19","doi-asserted-by":"crossref","unstructured":"Cumpston M, Li T, Page MJ, Chandler J, Welch VA, Higgins JP et al. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst. Rev. 2019;2019.","DOI":"10.1002\/14651858.ED000142"},{"key":"3783_CR20","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/jrsm.1411","volume":"12","author":"LA McGuinness","year":"2021","unstructured":"McGuinness LA, Higgins JP. Risk-of\u2010bias VISualization (robvis): an R package and Shiny web app for visualizing risk\u2010of\u2010bias assessments. Res Synth Methods. 2021;12:55\u201361.","journal-title":"Res Synth Methods"},{"key":"3783_CR21","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177\u201388.","journal-title":"Control Clin Trials"},{"key":"3783_CR22","first-page":"719","volume":"22","author":"N Mantel","year":"1959","unstructured":"Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of Disease. J Natl Cancer Inst. 1959;22:719\u201348.","journal-title":"J Natl Cancer Inst"},{"key":"3783_CR23","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629\u201334.","journal-title":"BMJ"},{"key":"3783_CR24","doi-asserted-by":"publisher","first-page":"601","DOI":"10.55563\/clinexprheumatol\/bz64na","volume":"39","author":"T Costa Pires","year":"2021","unstructured":"Costa Pires T, Caparr\u00f3s-Ruiz R, Gaspar P, Isenberg DA. Prevalence and outcome of thrombocytopenia in systemic lupus erythematous: single-centre cohort analysis. Clin Exp Rheumatol. 2021;39:601\u20135.","journal-title":"Clin Exp Rheumatol"},{"key":"3783_CR25","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1590\/S0365-05962010000200004","volume":"85","author":"LM Gon\u00e7alves","year":"2010","unstructured":"Gon\u00e7alves LM, Bezerra J\u00fanior JR, Cruz MC. Clinical evaluation of oral lesions associated with dermatologic Diseases. An Bras Dermatol. 2010;85:150\u20136.","journal-title":"An Bras Dermatol"},{"key":"3783_CR26","first-page":"146","volume":"5","author":"H Ahadian","year":"2017","unstructured":"Ahadian H, Ardakani T, Zahmati A, Owlia M, Zokaee H. Oral and Temporomandibular Joint Signs and symptoms in new cases of autoimmune connective-tissue Diseases before the treatment onset. Ann Dent Spec Vol. 2017;5:146.","journal-title":"Ann Dent Spec Vol"},{"key":"3783_CR27","doi-asserted-by":"publisher","first-page":"153","DOI":"10.7150\/ijms.38914","volume":"17","author":"V Crincoli","year":"2020","unstructured":"Crincoli V, Piancino MG, Iannone F, Errede M, Di Comite M. Temporomandibular disorders and oral features in systemic Lupus Erythematosus patients: an observational study of symptoms and signs. Int J Med Sci. 2020;17:153.","journal-title":"Int J Med Sci"},{"key":"3783_CR28","doi-asserted-by":"publisher","first-page":"4995","DOI":"10.3390\/jcm10214995","volume":"10","author":"A Buonavoglia","year":"2021","unstructured":"Buonavoglia A, Leone P, Prete M, Solimando AG, Guastadisegno C, Lanave G, et al. Epstein\u2013Barr Virus in Salivary samples from systemic Lupus Erythematosus patients with oral lesions. J Clin Med. 2021;10:4995.","journal-title":"J Clin Med"},{"key":"3783_CR29","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic Lupus Erythematosus. Arthritis Rheum. 1997;40:1725.","journal-title":"Arthritis Rheum"},{"key":"3783_CR30","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1002\/art.1780251101","volume":"25","author":"EM Tan","year":"1982","unstructured":"Tan EM, Cohen AS, Fries JF, Masi AT, Mcshane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic Lupus Erythematosus. Arthritis Rheum. 1982;25:1271\u20137.","journal-title":"Arthritis Rheum"},{"key":"3783_CR31","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1002\/art.34473","volume":"64","author":"M Petri","year":"2012","unstructured":"Petri M, Orbai AM, Alarc\u00f3n GS, Gordon C, Merrill JT, Fortin PR, et al. Derivation and validation of the systemic Lupus International collaborating clinics classification criteria for systemic Lupus Erythematosus. Arthritis Rheumatol. 2012;64:2677\u201386.","journal-title":"Arthritis Rheumatol"},{"key":"3783_CR32","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1034\/j.1600-0714.2000.290402.x","volume":"29","author":"U Meyer","year":"2000","unstructured":"Meyer U, Kleinheinz J, Handschel J, Kruse-L\u00f6sler B, Weingart D, Joos U. Oral findings in three different groups of immunocompromised patients. J Oral Pathol Med. 2000;29:153\u20138.","journal-title":"J Oral Pathol Med"},{"key":"3783_CR33","doi-asserted-by":"crossref","unstructured":"Saeed HM, Amr EM, Rezk ARL, Abd Elmoneim W. Prevalence of oral manifestations in patients with Lupus Erythematosus in a sample of the Egyptian population: a hospital based cross-sectional study. F1000Res. 2021. 10.","DOI":"10.12688\/f1000research.55332.1"},{"key":"3783_CR34","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1177\/0961203312454589","volume":"21","author":"M Khatibi","year":"2012","unstructured":"Khatibi M, Shakoorpour A, Jahromi ZM, Ahmadzadeh A. The prevalence of oral mucosal lesions and related factors in 188 patients with systemic Lupus Erythematosus. Lupus. 2012;21:1312\u20135.","journal-title":"Lupus"},{"key":"3783_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-021-02614-8","volume":"23","author":"M Kudsi","year":"2021","unstructured":"Kudsi M, Nahas LD, Alsawah R, Hamsho A, Omar A. The prevalence of oral mucosal lesions and related factors in systemic Lupus Erythematosus patients. Arthritis Res Ther. 2021;23:1\u20135.","journal-title":"Arthritis Res Ther"},{"key":"3783_CR36","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/art.1780210110","volume":"21","author":"JD Urman","year":"1978","unstructured":"Urman JD, Lowenstein MB, Abeles M, Weinstein A. Oral mucosal ulceration in systemic Lupus Erythematosus. Arthritis Rheum. 1978;21:58\u201361.","journal-title":"Arthritis Rheum"},{"key":"3783_CR37","first-page":"7242","volume":"13","author":"W Wang","year":"2021","unstructured":"Wang W, Gao H. The combined detection of autoantibody characteristics in systemic Lupus Erythematosus. Am J Transl Res. 2021;13:7242.","journal-title":"Am J Transl Res"},{"key":"3783_CR38","first-page":"423","volume":"112","author":"A Kuhn","year":"2015","unstructured":"Kuhn A, Bonsmann G, Anders H-J, Herzer P, Tenbrock K, Schneider M. The diagnosis and treatment of systemic Lupus Erythematosus. Dtsch \u00c4rzteblatt Int. 2015;112:423.","journal-title":"Dtsch \u00c4rzteblatt Int"},{"key":"3783_CR39","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1080\/14740338.2019.1685978","volume":"18","author":"LM Wise","year":"2019","unstructured":"Wise LM, Stohl W. The safety of belimumab for the treatment of systemic Lupus Erythematosus. Expert Opin Drug Saf. 2019;18:1133\u201344.","journal-title":"Expert Opin Drug Saf"},{"key":"3783_CR40","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1093\/rheumatology\/ket160","volume":"52","author":"G Murphy","year":"2013","unstructured":"Murphy G, Isenberg D. Effect of gender on clinical presentation in systemic Lupus Erythematosus. Rheumatology. 2013;52:2108\u201315.","journal-title":"Rheumatology"},{"key":"3783_CR41","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.coi.2004.09.007","volume":"16","author":"SK Nath","year":"2004","unstructured":"Nath SK, Kilpatrick J, Harley JB. Genetics of human systemic Lupus Erythematosus: the emerging picture. Curr Opin Immunol. 2004;16:794\u2013800.","journal-title":"Curr Opin Immunol"},{"key":"3783_CR42","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.berh.2008.05.003","volume":"22","author":"M Tikly","year":"2008","unstructured":"Tikly M, Navarra SV. Lupus in the developing world\u2013is it any different? Best Pract Res Clin Rheumatol. 2008;22:643\u201355.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"3783_CR43","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1177\/0961203313496299","volume":"22","author":"R Jasmin","year":"2013","unstructured":"Jasmin R, Sockalingam S, Cheah T, Goh K. Systemic Lupus Erythematosus in the multiethnic Malaysian population: Disease expression and ethnic differences revisited. Lupus. 2013;22:967\u201371.","journal-title":"Lupus"},{"key":"3783_CR44","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1177\/0961203316676380","volume":"26","author":"A Budhoo","year":"2017","unstructured":"Budhoo A, Mody G, Dubula T, Patel N, Mody P. Comparison of ethnicity, gender, age of onset and outcome in South africans with systemic Lupus Erythematosus. Lupus. 2017;26:438\u201346.","journal-title":"Lupus"},{"key":"3783_CR45","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00296-014-3057-4","volume":"35","author":"C Teh","year":"2015","unstructured":"Teh C, Ling G, Aishah WS. The Sarawak lupus cohort: clinical features and Disease patterns of 633 SLE patients in a single tertiary centre from East Malaysia. Rheumatol Int. 2015;35:153\u20137.","journal-title":"Rheumatol Int"},{"key":"3783_CR46","first-page":"1241","volume":"11","author":"Q Pan","year":"2019","unstructured":"Pan Q, Chen J, Guo L, Lu X, Liao S, Zhao C, et al. Mechanistic insights into environmental and genetic risk factors for systemic Lupus Erythematosus. Am J Transl Res. 2019;11:1241.","journal-title":"Am J Transl Res"},{"key":"3783_CR47","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1080\/08916930701357125","volume":"40","author":"M Bijl","year":"2007","unstructured":"Bijl M, Reefman E, Limburg PC, Kallenberg CG. Inflammatory clearance of apoptotic cells after UVB challenge. Autoimmunity. 2007;40:244\u20138.","journal-title":"Autoimmunity"},{"key":"3783_CR48","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1177\/0961203308089990","volume":"17","author":"LE Munoz","year":"2008","unstructured":"Munoz LE, van Bavel C, Franz S, Berden J, Herrmann M, Van Der Vlag J. Apoptosis in the pathogenesis of systemic Lupus Erythematosus. Lupus. 2008;17:371\u20135.","journal-title":"Lupus"},{"key":"3783_CR49","doi-asserted-by":"publisher","first-page":"i55","DOI":"10.1093\/rheumatology\/kew427","volume":"56","author":"O Zharkova","year":"2017","unstructured":"Zharkova O, Celhar T, Cravens PD, Satterthwaite AB, Fairhurst A-M, Davis LS. Pathways leading to an immunological Disease: systemic Lupus Erythematosus. Rheumatology. 2017;56:i55\u2013i66.","journal-title":"Rheumatology"},{"key":"3783_CR50","doi-asserted-by":"publisher","first-page":"678680","DOI":"10.3389\/fpubh.2021.678680","volume":"9","author":"CY Wright","year":"2021","unstructured":"Wright CY, Norval M. Health risks associated with excessive exposure to solar ultraviolet radiation among outdoor workers in South Africa: an overview. Front Public Health. 2021;9:678680.","journal-title":"Front Public Health"},{"key":"3783_CR51","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s00296-016-3450-2","volume":"36","author":"S Sousa","year":"2016","unstructured":"Sousa S, Gon\u00e7alves M, In\u00eas L, Eug\u00e9nio G, Jesus D, Fernandes S, et al. Clinical features and long-term outcomes of systemic Lupus Erythematosus: comparative data of childhood, adult and late-onset Disease in a national register. Rheumatol Int. 2016;36:955\u201360.","journal-title":"Rheumatol Int"},{"key":"3783_CR52","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1177\/0961203314563817","volume":"24","author":"T Tarr","year":"2015","unstructured":"Tarr T, D\u00e9rfalvi B, Gy\u0151ri N, Sz\u00e1nt\u00f3 A, Siminszky Z, Malik A, et al. Similarities and differences between pediatric and adult patients with systemic Lupus Erythematosus. Lupus. 2015;24:796\u2013803.","journal-title":"Lupus"},{"key":"3783_CR53","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1177\/0961203315591024","volume":"24","author":"J Choi","year":"2015","unstructured":"Choi J, Park D, Kang J, Yim Y, Lee K, Lee J, et al. Comparison of clinical and serological differences among juvenile-, adult-, and late-onset systemic Lupus Erythematosus in Korean patients. Lupus. 2015;24:1342\u20139.","journal-title":"Lupus"},{"key":"3783_CR54","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1093\/rheumatology\/ket488","volume":"53","author":"B Amaral","year":"2014","unstructured":"Amaral B, Murphy G, Ioannou Y, Isenberg DA. A comparison of the outcome of adolescent and adult-onset systemic Lupus Erythematosus. Rheumatology (Oxford). 2014;53:1130\u20135.","journal-title":"Rheumatology (Oxford)"}],"container-title":["BMC Oral Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-023-03783-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12903-023-03783-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-023-03783-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T12:03:34Z","timestamp":1703160214000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcoralhealth.biomedcentral.com\/articles\/10.1186\/s12903-023-03783-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,21]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3783"],"URL":"https:\/\/doi.org\/10.1186\/s12903-023-03783-5","relation":{},"ISSN":["1472-6831"],"issn-type":[{"value":"1472-6831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,21]]},"assertion":[{"value":"14 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"1030"}}